Bavisant

Research use only, not for human use.

Bavisant is a selective and orally active Human H3 receptor antagonist. Bavisant can be used in research on mechanisms of action, involving wakefulness and cognition and the treatment for ADHD.

Bavisant is a selective and orally active Human H3 receptor antagonist. Bavisant can be used in research on mechanisms of action, involving wakefulness and cognition and the treatment for ADHD.(In Vivo):Mean change from baseline in the total ADHD-RS-IV score at day 42 (primary efficacy endpoint) was -8.8 in the placebo group versus -9.3, -11.2, and -12.2 in the Bavisant 1 mg/day, 3 mg/day, and 10 mg/day groups, respectively; the change in the 10 mg/day group was not statistically superior to placebo, and hence statistical comparisons of the 1 mg/day and 3 mg/day groups with placebo based on a step-down closed testing procedure were not performed.

——

Bavisant increases acetylcholine levels in rat frontal cortex.

JNJ-31001074

GPCR/G Protein

Histamine Receptor

Histamine Receptor

——

——

929622-08-2

329.444

C19H27N3O2

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (303.55 mM)

O=C(N1CCN(CC1)C1CC1)c1ccc(CN2CCOCC2)cc1

——

(-20℃)

With Ice Pack

≥ 2 years